(NASDAQ:DBGI), Austin, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) — Digital Brands Group, Inc. (NASDAQ:DBGI) (the “Company,” “Digital Brands Group” or “DBG”) today announces its partnership with SECUR3D Inc (“SECUR3D”). to expand its suite of technology tools for eCommerce brands. These collaborations strengthen the Company's ability to protect brand assets and accelerate growth through next-generation AI […]
(NASDAQ:GTBP), Phase 1 trial evaluating GTB-3650 TriKE(R) for relapsed or refractory (r/r) CD33 expressing hematologic malignancies continues to actively enroll with the next update anticipated in Q1 2026 GTB-5550 TriKE(R) IND submission for B7H3-expressing solid tumors expected in late December 2025 or January 2026 SAN FRANCISCO, CALIFORNIA, Nov. 14, 2025 (GLOBE NEWSWIRE) — GT Biopharma,
(NasdaqGM:ALLR), Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trial Advanced DRP(R) platform through new licensing agreement TARPON SPRINGS, Fla., November 14, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company
Scento Invests EUR25M to Revolutionize European Luxury Perfume Discovery and Transform Online Fragrance Shopping at Scale Paris-Based Fragrance Technology Leader Commits to 3-Year Investment in AI-Driven Personalization, Authenticated Supply Network, and Digital Perfumery Innovation Across 19 European Market GlobeNewswire November 14, 2025 Paris, France, Nov. 14, 2025 (GLOBE NEWSWIRE) — Scento, Europe's premium fragrance discovery
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test GlobeNewswire November 14, 2025 DUBLIN, Nov. 14, 2025 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with a leading bioinformatics company to
PureCycle, Churchill Container Win U.S. Plastics Pact Sustainable Packaging Innovation Award for PCR Content GlobeNewswire November 14, 2025 ORLANDO, Fla., Nov. 14, 2025 (GLOBE NEWSWIRE) — PureCycle Technologies, Inc. (Nasdaq: PCT), announced today that the Company and Churchill Container have won the 2025 U.S. Plastics Pact Sustainable Packaging Innovation Award in the Postconsumer Recycled (PCR)
Safe and Green Development Corporation Announces 4,200% Year-Over-Year Revenue Growth in Q3 2025 and Strong Momentum Into Fourth Quarter GlobeNewswire November 14, 2025 MIAMI, Nov. 14, 2025 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD) (“SGD,” the “Company,” or “Safe and Green Development”) today announced financial results for the three and nine months
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate GlobeNewswire November 14, 2025 Windtree has a total of 59 issued or allowed patents and 17 pending patents for Istaroxime and its SERCA2a activators Windtree received recent notification of allowed Istaroxime patents for acute heart failure in Canada and Mexico
Reading International Reports Third Quarter 2025 Results GlobeNewswire November 14, 2025 Earnings Call Webcast to Discuss Third Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, November 18, 2025 NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate
Boston Hemp Inc. Issues Statement Calling for Full Protection of Legal Hemp Under the 2018 Farm Bill Framework GlobeNewswire November 14, 2025 BOSTON, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) — via IBN – Boston Hemp Inc. today released a formal statement urging federal policymakers to uphold the existing definition and legal status of hemp under